Myofascial pelvic pain: the forgotten player in chronic pelvic pain.
Journal
Current opinion in obstetrics & gynecology
ISSN: 1473-656X
Titre abrégé: Curr Opin Obstet Gynecol
Pays: England
ID NLM: 9007264
Informations de publication
Date de publication:
22 May 2024
22 May 2024
Historique:
medline:
5
6
2024
pubmed:
5
6
2024
entrez:
5
6
2024
Statut:
aheadofprint
Résumé
In this review article, we discuss myofascial-related chronic pelvic pain, pathophysiology, symptomology, and management options. Despite high prevalence of myofascial pelvic pain, screening is not routinely performed by providers. Treatment modalities include pelvic floor physical therapy, pelvic floor trigger point injections with anesthetics or botulinum toxin A and cryotherapy. Other adjunct modalities, such as muscle relaxants and intravaginal benzodiazepines, are used, but data regarding their effectiveness is sparse. Myofascial pelvic pain is an important, though overlooked component of chronic pelvic pain. Multimodal, multidisciplinary approach including patient education, pelvic floor physical therapy, and trigger point injections is the mainstay of the management of myofascial pelvic pain.
Identifiants
pubmed: 38837702
doi: 10.1097/GCO.0000000000000966
pii: 00001703-990000000-00133
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician 2014; 17:E141–E147.
Hutton D, Mustafa A, Patil S, et al. The burden of chronic pelvic pain (CPP): costs and quality of life of women and men with CPP treated in outpatient referral centers. PLoS One 2023; 18:e0269828.
Sperschneider ML, Hengartner MP, Kohl-Schwartz A, et al. Does endometriosis affect professional life? A matched case-control study in Switzerland, Germany and Austria. BMJ Open 2019; 9:e019570.
Mathias SD, Kuppermann M, Liberman RF, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996; 87:321–327.
Tu FF, Holt J, Gonzales J, Fitzgerald CM. Physical therapy evaluation of patients with chronic pelvic pain: a controlled study. Am J Obstet Gynecol 2008; 198:272 e1-7.
Meister MR, Shivakumar N, Sutcliffe S, et al. Physical examination techniques for the assessment of pelvic floor myofascial pain: a systematic review. Am J Obstet Gynecol 2018; 219:497.e1–497.e13.
Tu FF, As-Sanie S, Steege JF. Prevalence of pelvic musculoskeletal disorders in a female chronic pelvic pain clinic. J Reprod Med 2006; 51:185–189.
Bassaly R, Tidwell N, Bertolino S, et al. Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J 2011; 22:413–418.
Pastore EA, Katzman WB. Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain. J Obstet Gynecol Neonatal Nurs 2012; 41:680–691.
Liu A, Chedid V, Wang XJ, et al. Clinical presentation and characteristics of pelvic floor myofascial pain in patients presenting with constipation. Neurogastroenterol Motil 2020; 32:e13845.
US Elsevier Health. [cited 2024 Jan 7]. Evidence-based physical therapy for the pelvic F - 9780702044434. Available at: https://www.us.elsevierhealth.com/evidence-based-physical-therapy-for-the-pelvic-floor-9780702044434.html.
Tucker DR, Noga HL, Lee C, et al. Pelvic pain comorbidities associated with quality of life after endometriosis surgery. Am J Obstet Gynecol 2023; 229:147.e1–147.e20.
Lippincott Williams & Wilkins, Travell JG, Simons DG. Myofascial pain and dysfunction: the trigger point manual. 1992; p. 660.
Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther 2008; 12:371–384.
Lippincott Williams & Wilkins, Mense S, Simons DG, Russell IJ. Muscle pain: understanding its nature, diagnosis, and treatment. 2001; p. 410.
Treaster D, Marras WS, Burr D, et al. Myofascial trigger point development from visual and postural stressors during computer work. J Electromyogr Kinesiol 2006; 16:115–124.
Huguenin LK. Myofascial trigger points: the current evidence. Physical Ther Sport 2004; 5:2–12.
Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993; 54:241–289.
Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol 1984; 356:443–458.
Volcheck MM, Graham SM, Fleming KC, et al. Central sensitization, chronic pain, and other symptoms: Better understanding, better management. CCJM 2023; 90:245–254.
Kavvadias T, Baessler K, Schuessler B. Pelvic pain in urogynaecology. Part I: evaluation, definitions and diagnoses. Int Urogynecol J 2011; 22:385–393.
Butrick CW. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am 2009; 36:707–722.
MEISTER MR, SUTCLIFFE S, BADU A, et al. Pelvic floor myofascial pain severity and pelvic floor disorder symptom bother: is there a correlation? Am J Obstet Gynecol 2019; 221:235e1–235e15.
Meister MR, Sutcliffe S, Ghetti C, et al. Development of a standardized, reproducible screening examination for assessment of pelvic floor myofascial pain. Am J Obstet Gynecol 2019; 220:255.e1–255.e9.
Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62:600–610.
Wallace SL, Miller LD, Mishra K. Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women. Curr Opin Obstet Gynecol 2019; 31:485–493.
van Reijn-Baggen DA, Han-Geurts IJM, Voorham-van der Zalm PJ, et al. Pelvic floor physical therapy for pelvic floor hypertonicity: a systematic review of treatment efficacy. Sex Med Rev 2022; 10:209–230.
Vandyken C, Hilton S. Physical therapy in the treatment of central pain mechanisms for female sexual pain. Sex Med Rev 2017; 5:20–30.
FitzGerald MP, Payne CK, Lukacz ES, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol 2012; 187:2113–2118.
Fitzgerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2013; 189: (1 Suppl): S75–S85.
Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol 2006; 176 (4 Pt 1):1534–1538. discussion 1538–9.
Wurn LJ, Wurn BF, King CR, et al. Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique. MedGenMed 2004; 6:47.
Oyama IA, Rejba A, Lukban JC, et al. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 2004; 64:862–865.
Anderson R, Wise D, Sawyer T, Nathanson BH. Safety and effectiveness of an internal pelvic myofascial trigger point wand for urologic chronic pelvic pain syndrome. Clin J Pain 2011; 27:764–768.
K100934.pdf [Internet]. [cited 2024 Jan 7]. Available at: https://www.accessdata.fda.gov/cdrh_docs/reviews/K100934.pdf.
Jb F, Tj K, Jj S. Electrical stimulation in the treatment of pelvic pain due to levator ani spasm. The Journal of reproductive medicine. 2003 Aug [cited 2024 Jan 7];48(8). Available at: https://pubmed.ncbi.nlm.nih.gov/12971135/.
Nappi RE, Ferdeghini F, Abbiati I, et al. Electrical stimulation (ES) in the management of sexual pain disorders. J Sex Marital Ther 2003; 29: (Suppl 1): 103–110.
Cerezo-Téllez E, Torres-Lacomba M, Fuentes-Gallardo I, et al. Effectiveness of dry needling for chronic nonspecific neck pain: a randomized, single-blinded, clinical trial. Pain 2016; 157:1905–1917.
Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth 1997; 22:89–101.
Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 2001; 82:986–992.
Fouad LS, Pettit PD, Threadcraft M, et al. Trigger point injections for pelvic floor myofascial spasm refractive to primary therapy. J Endometr Pelvic Pain Disord 2017; 9:125–130.
Zoorob D, South M, Karram M, et al. A pilot randomized trial of levator injections versus physical therapy for treatment of pelvic floor myalgia and sexual pain. Int Urogynecol J 2015; 26:845–852.
Abbott JA, Jarvis SK, Lyons SD, et al. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 2006; 108:915–923.
Dessie SG, Bargen EV, Hacker MR, et al. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain. Am J Obstet Gynecol 2019; 221:517.e1–517.e9.
Meister MR, Brubaker A, Sutcliffe S, Lowder JL. Effectiveness of botulinum toxin for treatment of symptomatic pelvic floor myofascial pain in women: a systematic review and meta-analysis. Female Pelvic Med Reconstr Surg 2021; 27:e152–e160.
Ahmed S, Subramaniam S, Sidhu K, et al. Effect of local anesthetic versus botulinum toxin-A injections for myofascial pain disorders: a systematic review and meta-analysis. Clin J Pain 2019; 35:353–367.
Parsons BA, Goonewardene S, Dabestani S, et al. The benefits and harms of botulinum toxin-A in the treatment of chronic pelvic pain syndromes: a systematic review by the European Association of Urology Chronic Pelvic Pain panel. Eur Urol Focus 2022; 8:320–338.
Wang H, Olivero W, Wang D, Lanzino G. Cold as a therapeutic agent. Acta Neurochir (Wien) 2006; 148:565–570. discussion 569–70.
Morsy H, Meister M, Spitznagle T, et al. A Pilot randomized controlled trial of vaginal cryotherapy for the treatment of pelvic floor myofascial pain. Int Urogynecol J 2023; 35:215–225.
Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 2004; 51:9–13.
Stone RH, Abousaud M, Abousaud A, Kobak W. A systematic review of intravaginal diazepam for the treatment of pelvic floor hypertonic disorder. J Clin Pharmacol 2020; 60: (Suppl 2): S110–S120.
Larish AM, Dickson RR, Kudgus RA, et al. Vaginal diazepam for nonrelaxing pelvic floor dysfunction: the pharmacokinetic profile. J Sex Med 2019; 16:763–766.
Barros-Neto JA, Souza-Machado A, Kraychete DC, et al. Selenium and zinc status in chronic myofascial pain: serum and erythrocyte concentrations and food intake. PLoS One 2016; 11:e0164302.
Okumus M, Ceceli E, Tuncay F, et al. The relationship between serum trace elements, vitamin B12, folic acid and clinical parameters in patients with myofascial pain syndrome. J Back Musculoskelet Rehabil 2010; 23:187–191.
Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463–1470.
Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg 2011; 17:36–39.
Elma Ö, Yilmaz ST, Deliens T, et al. Do nutritional factors interact with chronic musculoskeletal pain? A systematic review. J Clin Med 2020; 9:E702.
Brämberg EB, Bergström G, Jensen I, et al. Effects of yoga, strength training and advice on back pain: a randomized controlled trial. BMC Musculoskelet Disord 2017; 18:132.
Saxena R, Gupta M, Shankar N, et al. Effects of yogic intervention on pain scores and quality of life in females with chronic pelvic pain. Int J Yoga 2017; 10:9–15.